Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Novo Nordisk A/S NVO reported first-quarter 2025 earnings of 92 cents per American Depositary Receipt (ADR), which matched ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

In February, the compounding groups filed a lawsuit challenging the FDA’s decision to remove semaglutide from the drug shortage list. The plaintiffs argue that this action was arbitrary ...

With the FDA's resolution of the shortage of Ozempic ® and Wegovy ®, as left in place by this court ruling, it is illegal under US compounding laws to make or sell knockoff "semaglutide drugs ...

That came in response to a February lawsuit from a compounding trade group against the Food and Drug Administration's determination that the active ingredient in those drugs, semaglutide ...

A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...